JP2023538366A5 - - Google Patents
Info
- Publication number
- JP2023538366A5 JP2023538366A5 JP2023511947A JP2023511947A JP2023538366A5 JP 2023538366 A5 JP2023538366 A5 JP 2023538366A5 JP 2023511947 A JP2023511947 A JP 2023511947A JP 2023511947 A JP2023511947 A JP 2023511947A JP 2023538366 A5 JP2023538366 A5 JP 2023538366A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063066565P | 2020-08-17 | 2020-08-17 | |
| US63/066,565 | 2020-08-17 | ||
| PCT/US2021/046217 WO2022040128A2 (en) | 2020-08-17 | 2021-08-17 | Constrained conditionally activated binding proteins |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023538366A JP2023538366A (ja) | 2023-09-07 |
| JPWO2022040128A5 JPWO2022040128A5 (https=) | 2024-08-22 |
| JP2023538366A5 true JP2023538366A5 (https=) | 2024-08-22 |
| JP7832926B2 JP7832926B2 (ja) | 2026-03-18 |
Family
ID=77655705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023511947A Active JP7832926B2 (ja) | 2020-08-17 | 2021-08-17 | 制約され、条件付きで活性化された結合タンパク質 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240026011A1 (https=) |
| EP (1) | EP4196503A2 (https=) |
| JP (1) | JP7832926B2 (https=) |
| KR (1) | KR20230048146A (https=) |
| CN (1) | CN116419925A (https=) |
| AR (1) | AR123266A1 (https=) |
| AU (1) | AU2021329290A1 (https=) |
| CA (1) | CA3191431A1 (https=) |
| CL (1) | CL2023000477A1 (https=) |
| CO (1) | CO2023002164A2 (https=) |
| EC (1) | ECSP23018458A (https=) |
| IL (1) | IL300598A (https=) |
| MX (1) | MX2023002002A (https=) |
| PE (1) | PE20230856A1 (https=) |
| TW (1) | TW202214707A (https=) |
| WO (1) | WO2022040128A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12128102B2 (en) | 2016-03-08 | 2024-10-29 | Takeda Pharmaceutical Company Limited | Constrained conditionally activated binding proteins |
| IL302613B2 (en) | 2017-09-08 | 2025-04-01 | Maverick Therapeutics Inc | Binding proteins are activated under limited conditions |
| WO2023164551A1 (en) * | 2022-02-23 | 2023-08-31 | Takeda Pharmaceutical Company Limited | Conditionally bispecific binding proteins |
| WO2024040228A2 (en) * | 2022-08-19 | 2024-02-22 | Regents Of The University Of Minnesota | Cd83 binding proteins |
| WO2024040220A2 (en) * | 2022-08-19 | 2024-02-22 | Regents Of The University Of Minnesota | Cd83 binding fusion proteins |
| EP4583921A1 (en) * | 2022-09-07 | 2025-07-16 | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | Anti-trop2/egfr antibodies and uses thereof |
| WO2024147897A2 (en) * | 2023-01-05 | 2024-07-11 | Harpoon Therapeutics, Inc. | Trop2 targeting trispecific protein for treatment of cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG2014010482A (en) | 2011-08-17 | 2014-04-28 | Glaxo Group Ltd | Modified proteins and peptides |
| KR20230041739A (ko) | 2016-03-08 | 2023-03-24 | 매버릭 테라퓨틱스, 인크. | 유도성 결합 단백질 및 사용 방법 |
| IL302613B2 (en) * | 2017-09-08 | 2025-04-01 | Maverick Therapeutics Inc | Binding proteins are activated under limited conditions |
| WO2020181140A1 (en) * | 2019-03-05 | 2020-09-10 | Maverick Therapeutics, Inc. | Constrained conditionally activated binding proteins |
-
2021
- 2021-08-17 PE PE2023000289A patent/PE20230856A1/es unknown
- 2021-08-17 JP JP2023511947A patent/JP7832926B2/ja active Active
- 2021-08-17 TW TW110130298A patent/TW202214707A/zh unknown
- 2021-08-17 IL IL300598A patent/IL300598A/en unknown
- 2021-08-17 MX MX2023002002A patent/MX2023002002A/es unknown
- 2021-08-17 WO PCT/US2021/046217 patent/WO2022040128A2/en not_active Ceased
- 2021-08-17 CN CN202180066644.9A patent/CN116419925A/zh active Pending
- 2021-08-17 KR KR1020237009028A patent/KR20230048146A/ko not_active Withdrawn
- 2021-08-17 EP EP21766347.5A patent/EP4196503A2/en active Pending
- 2021-08-17 CA CA3191431A patent/CA3191431A1/en active Pending
- 2021-08-17 AU AU2021329290A patent/AU2021329290A1/en not_active Abandoned
- 2021-08-17 US US18/021,730 patent/US20240026011A1/en active Pending
- 2021-08-17 AR ARP210102304A patent/AR123266A1/es not_active Application Discontinuation
-
2023
- 2023-02-16 CL CL2023000477A patent/CL2023000477A1/es unknown
- 2023-02-27 CO CONC2023/0002164A patent/CO2023002164A2/es unknown
- 2023-03-16 EC ECSENADI202318458A patent/ECSP23018458A/es unknown